Medical Condition News

RSS
Novel method for evaluating treatment of obesity-related food behavior

Novel method for evaluating treatment of obesity-related food behavior

Novel feedback provides mechanistic link between chronic inflammation and carcinogenesis

Novel feedback provides mechanistic link between chronic inflammation and carcinogenesis

New technology uses nano-flares to catch metastatic breast cancer cells early on

New technology uses nano-flares to catch metastatic breast cancer cells early on

New drug for patients with leukaemia and lymphoma puts an end to chemotherapy

New drug for patients with leukaemia and lymphoma puts an end to chemotherapy

New stool-based screening test detects 92% of colorectal cancer

New stool-based screening test detects 92% of colorectal cancer

Real-time cervical cancer diagnostics: an interview with Sameer Kothari, Chief Executive of Zilico

Real-time cervical cancer diagnostics: an interview with Sameer Kothari, Chief Executive of Zilico

Genomic analysis to study cancer in dogs can help develop new therapies for human cancers

Genomic analysis to study cancer in dogs can help develop new therapies for human cancers

Novan Therapeutics reports positive results from SB204 Phase 2 study for treatment of acne vulgaris

Novan Therapeutics reports positive results from SB204 Phase 2 study for treatment of acne vulgaris

Celgene reiterates commitment to increase awareness and understanding of pancreatic cancer

Celgene reiterates commitment to increase awareness and understanding of pancreatic cancer

Research finds youth, wealth and education to be risk factors linked with violent radicalisation

Research finds youth, wealth and education to be risk factors linked with violent radicalisation

Occasional drinking and physically activity linked with reduced risk of developing visual impairment

Occasional drinking and physically activity linked with reduced risk of developing visual impairment

Ipsen: Dysport Phase IIa clinical trial effective in treatment of NDO

Ipsen: Dysport Phase IIa clinical trial effective in treatment of NDO

Researchers use "big data" analytics to predict triple-negative breast cancer and other cancers with 95% accuracy

Researchers use "big data" analytics to predict triple-negative breast cancer and other cancers with 95% accuracy

Study: Daily dietary supplements not associated with reduced risk for CVD in elderly

Study: Daily dietary supplements not associated with reduced risk for CVD in elderly

Study provides evidence that sepsis-related mortality has steadily decreased over time

Study provides evidence that sepsis-related mortality has steadily decreased over time

Restless legs syndrome alters expression of critical gene during fetal development of brain

Restless legs syndrome alters expression of critical gene during fetal development of brain

RaySearch signs distribution agreement with AlphaXRT for RayStation

RaySearch signs distribution agreement with AlphaXRT for RayStation

PredictND project aims at validating new procedures for early diagnosis of memory disorders

PredictND project aims at validating new procedures for early diagnosis of memory disorders

Added benefit of ipilimumab in advanced melanoma not proven for non-pretreated patients

Added benefit of ipilimumab in advanced melanoma not proven for non-pretreated patients

Elevated body temperature linked to fatigue in relapsing-remitting multiple sclerosis

Elevated body temperature linked to fatigue in relapsing-remitting multiple sclerosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.